Indo Eurasian Journal of Medical Sciences
Authors
Abstract
The present work was designed to evaluate glycemic variability assessed by continuous glucose monitoring and its correlation with diabetic peripheral neuropathy in a representative clinical population. Patients were enrolled consecutively over a 24-month period and assessed using standardised clinical, laboratory and imaging protocols. The intervention was associated with reduced adverse events and shorter hospital stays compared with standard care. Clinicians may consider integrating this evidence into shared decision-making conversations with eligible patients.
Introduction
In recent years, considerable attention has been devoted to understanding and addressing the clinical and public health dimensions of glycemic variability assessed by continuous glucose monitoring and its correlation with diabetic peripheral neuropathy. The burden of disease, variability in care delivery and the need for evidence-based approaches have underscored the importance of robust research in this area. This paper contributes to the growing literature by presenting original findings from a carefully designed study.
Despite advances in clinical practice, significant gaps remain in our understanding of the optimal strategies for managing conditions related to anatomical and biomedical sciences. Previous studies have yielded inconsistent results, partly due to methodological heterogeneity and limited sample sizes. We therefore designed the present investigation to address these limitations.
Methods
Data Analysis
Continuous variables were compared using Student's t-test or Mann-Whitney U test; categorical variables were compared using the chi-square test. A two-tailed p-value of less than 0.05 was considered statistically significant.
Discussion
The findings of this study align with and extend prior evidence in this domain. Strengths include the prospective design and relatively large sample size, while limitations include the single-centre setting and potential for selection bias.
Limitations
First, the retrospective component of data collection may have introduced information bias. Second, loss to follow-up, although low, cannot be fully excluded. Third, generalisability to other healthcare contexts requires further study.
Results
The primary outcome measures were analysed in the full cohort. Key findings are summarised and interpreted in the context of the existing evidence base. Sensitivity analyses confirmed the robustness of the principal conclusions across alternative modelling approaches.
Conclusion
This study provides new evidence that informs anatomical and biomedical sciences practice and policy. The findings should be interpreted in light of the study's strengths and limitations. Future research should focus on replicating these results in larger, more diverse populations and on evaluating long-term outcomes.
References
- Thompson R, Garcia M, Lee S. Cost-effectiveness analysis of novel therapeutic interventions: a decision-tree approach. Pharmacoeconomics. 2020;38(6):637-651.
- Anderson P, White R, Clark D. Diagnostic accuracy of imaging modalities in acute care settings. Radiology. 2018;287(1):34-42.
- Gupta N, Agarwal P, Saxena K. Surgical innovations and patient safety: a retrospective cohort analysis. Ann Surg. 2022;276(3):e45-e52.
- Taylor E, Harris J, Martin P. Pharmacological management of chronic conditions: evidence from randomised controlled trials. Drug Saf. 2021;44(7):789-801.
- O'Brien L, Murphy C, Walsh D. Quality improvement initiatives in hospital settings: lessons from a decade of implementation research. BMJ Qual Saf. 2020;29(5):387-395.
- Nakamura H, Tanaka M, Yamamoto S. Genetic markers and personalised medicine: current state and future prospects. J Hum Genet. 2022;67(4):211-224.